Total Liabilities - Gensight Biologics SA (PAR:SIGHT) - Alpha Spread

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.38 EUR -3.8%
Market Cap: 39.3m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gensight Biologics SA
Total Liabilities Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Total Liabilities
€39.8m
CAGR 3-Years
4%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Total Liabilities
€300.3m
CAGR 3-Years
-23%
CAGR 5-Years
21%
CAGR 10-Years
11%
Nanobiotix SA
PAR:NANO
Total Liabilities
€95.7m
CAGR 3-Years
15%
CAGR 5-Years
25%
CAGR 10-Years
37%
Innate Pharma SA
PAR:IPH
Total Liabilities
€122.7m
CAGR 3-Years
-3%
CAGR 5-Years
-6%
CAGR 10-Years
21%
Genfit SA
NASDAQ:GNFT
Total Liabilities
€105.9m
CAGR 3-Years
-21%
CAGR 5-Years
-13%
CAGR 10-Years
22%
Eurobio Scientific SA
PAR:ALERS
Total Liabilities
€141.3m
CAGR 3-Years
29%
CAGR 5-Years
28%
CAGR 10-Years
26%

See Also

What is Gensight Biologics SA's Total Liabilities?
Total Liabilities
39.8m EUR

Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Total Liabilities amounts to 39.8m EUR.

What is Gensight Biologics SA's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
25%

Over the last year, the Total Liabilities growth was -3%. The average annual Total Liabilities growth rates for Gensight Biologics SA have been 4% over the past three years , 25% over the past five years .

Back to Top